Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer E Lauret Marie Joseph, C Laheurte, M Jary, L Boullerot, K Asgarov, ... Cancer immunology research 8 (2), 268-279, 2020 | 33 | 2020 |
Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer E Picard, Y Godet, C Laheurte, M Dosset, J Galaine, L Beziaud, R Loyon, ... Oncoimmunology 8 (2), e1527498, 2019 | 29 | 2019 |
CIITA-transduced glioblastoma cells uncover a rich repertoire of clinically relevant tumor-associated HLA-II antigens G Forlani, J Michaux, HS Pak, F Huber, ELM Joseph, E Ramia, ... Molecular & Cellular Proteomics 20, 2021 | 25 | 2021 |
Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy ELM Joseph, A Kirilovsky, B Lecoester, C El Sissy, L Boullerot, L Rangan, ... Journal for immunotherapy of cancer 9 (7), 2021 | 21 | 2021 |
Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood J Boustani, ELM Joseph, E Martin, S Benhmida, B Lecoester, F Tochet, ... BMC immunology 22 (1), 38, 2021 | 10 | 2021 |
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer. Oncoimmunology. 2018; 7 (6): e1433981 M Dosset, TR Vargas, A Lagrange, R Boidot, F Végran, A Roussey, ... | 8 | 2018 |
Modulation of determinant factors to improve therapeutic combinations with immune checkpoint inhibitors M Dosset, ELM Joseph, T Rivera Vargas, L Apetoh Cells 9 (7), 1727, 2020 | 7 | 2020 |
Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A* 0201/DRB1* 0101 transgenic mice L Rangan, J Galaine, R Boidot, M Hamieh, M Dosset, J Francoual, ... Oncotarget 8 (30), 48959, 2017 | 6 | 2017 |
Rôles immunomodulateurs des MDSC Tie-2+ et de la radiochimiothérapie dans les cancers bronchiques non à petites cellules ELM Joseph Université Bourgogne Franche-Comté, 2019 | | 2019 |
Myeloid-derived suppressor cells are associated with a decrease of tumor antigen-specific Th1 immunity in non-small cell lung cancer O Adotevi, ELM Joseph, C Laheurte, M Dosset, E Fabre-Guillevin, ... Annals of Oncology 28, v582, 2017 | | 2017 |
Étude des mécanismes d’activation des réponses T CD4 antitumorale induites par la chimioradiothérapie: résultats préliminaires S Servagi-Vernat, E Lauret-Marie-Joseph, L Rangan, O Adotevi, C Bonin Cancer/Radiothérapie 20 (6-7), 756, 2016 | | 2016 |